[Fatal poisoning with propafenone: a case report documented with blood concentration levels]. 2003

Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond

UI MeSH Term Description Entries
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
March 2010, Journal of medical toxicology : official journal of the American College of Medical Toxicology,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
January 1988, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
May 2024, International journal of molecular sciences,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
September 1981, The New Zealand medical journal,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
January 1979, Zeitschrift fur Rechtsmedizin. Journal of legal medicine,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
December 1966, JAMA,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
April 1988, Scandinavian journal of work, environment & health,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
February 2004, Critical care (London, England),
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
January 1993, Minerva anestesiologica,
Catherine Palette, and Nadine Maroun, and Jean-Michel Gaulier, and Bruno Priolet, and Gérard Lachatre, and Jean-Pierre Bedos, and Charles Advenier, and Patrice Thérond
March 1988, Annales de cardiologie et d'angeiologie,
Copied contents to your clipboard!